NCT03428971

Brief Summary

It is suggested that P-wave terminal force (Ptf), a product of the amplitude (PAM) and the duration (PT) of the terminal phase of P-wave in lead V1, shows early delay in left atrial conduction, observed earlier that the dilatation of left atrium. The aim is to follow PT, PAM and Ptf changes during 5-year follow-up (5FU) and examine the relation of these changes to the number of AF episodes requiring hospitalisation (HOSP) for restoration of sinus rhythm (RSR).

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
600

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2018

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 2, 2018

Completed
10 days until next milestone

First Posted

Study publicly available on registry

February 12, 2018

Completed
17 days until next milestone

Study Start

First participant enrolled

March 1, 2018

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 7, 2020

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 7, 2020

Completed
Last Updated

January 22, 2020

Status Verified

January 1, 2020

Enrollment Period

2 years

First QC Date

February 2, 2018

Last Update Submit

January 20, 2020

Conditions

Keywords

atrial fibrillationp-wavehospitalization

Outcome Measures

Primary Outcomes (1)

  • Changes of P-wave time (PT), P-wave amplitude (PAM) and Ptf (P wave terminal force terminal V1-lead ) in 5-year follow-up (5FU).

    All measurements based on ECG recording during sinus rhythm only. * "P-wave time (PT)" defined as time (measured in milliseconds, \[ms\]) of negative deflection of P wave in V1 lead of the standard 12-lead ECG; * "P-wave amplitude (PAM)" defined as maximum amplitude (measured in millivolts, \[mV\]) of negative deflection of P wave in V1 lead of the standard 12-lead ECG; * "P-wave terminal force (Ptf)" is a product of the amplitude and the duration of the terminal phase of P-wave in lead V1; Ptf = PT x PAM \[ms x mV\]; * PT and PAM measured at index is defined as PT0 and PAM0, respectively * Calculated Ptf as a product of PT0 and PAM0 is defined as Ptf0; * PT and PAM measured at 5FU is defined as PT5 and PAM5, respectively; * Calculated Ptf as a product of PT5 and PAM5 is defined as Ptf5; * The change between PT0 and PT5 (PTC = PT5 - PT0) , PAM0 and PAM5 (PAMC = PAM5 - PAM0), Ptf0 and Ptf5 (PtfC = Ptf5 - Ptf0) will be calculated for each patient;

    5 years

Secondary Outcomes (3)

  • Correlation between index PT0, PAM0, Ptf0 and number of hospitalizations (HOSP) in 5-year follow-up

    5 years

  • Correlation between number of hospitalizations (HOSP) in 5- year follow-up and final PT5, PAM5, Ptf5 at the end of 5-year follow-up period.

    5 years

  • Correlation between changes of PT, PAM, Ptf (PTC, PAMC, PtfC) and number of hospitalizations (HOSP) in 5-year follow-up.

    5 years

Interventions

cardioversionPROCEDURE

Direct current (DC) cardioversion for sinus rhythm restoration

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with atrial fibrillation admitted between 1.1.2001 and 30.12.2012 for elective and emergency hospitalization aimed for restoration of sinus rhythms with DC cardioversion.

You may qualify if:

  • documented atrial fibrillation at admission
  • successful restoration of sinus rhythms documented in 12-leads ECG,
  • follow-up =\> 5 years

You may not qualify if:

  • arrhythmia other than atrial fibrillation at admission,
  • unsuccessful restoration of sinus rhythms,
  • successful restoration of sinus rhythms but missing 12-leads ECG recording,
  • previous ablation/operation within left atrium,
  • follow-up \< 5 years

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medical University of Lublin

Lublin, 20-091, Poland

RECRUITING

Related Publications (4)

  • Wojcik M, Kuniss M, Berkowitsch A, Neumann T. P-wave terminal force and atrial fibrillation: a lesson learned from old masters. Rev Esp Cardiol (Engl Ed). 2012 Jun;65(6):584-5; author reply 585. doi: 10.1016/j.recesp.2012.01.015. Epub 2012 Mar 31. No abstract available.

    PMID: 22465604BACKGROUND
  • Janin S, Wojcik M, Kuniss M, Berkowitsch A, Erkapic D, Zaltsberg S, Ecarnot F, Hamm CW, Pitschner HF, Neumann T. Pulmonary vein antrum isolation and terminal part of the P wave. Pacing Clin Electrophysiol. 2010 Jul;33(7):784-9. doi: 10.1111/j.1540-8159.2010.02754.x. Epub 2010 Mar 29.

    PMID: 20374516BACKGROUND
  • Ishida K, Hayashi H, Miyamoto A, Sugimoto Y, Ito M, Murakami Y, Horie M. P wave and the development of atrial fibrillation. Heart Rhythm. 2010 Mar;7(3):289-94. doi: 10.1016/j.hrthm.2009.11.012. Epub 2009 Nov 12.

    PMID: 20133209BACKGROUND
  • Martin Garcia A, Jimenez-Candil J, Hernandez J, Martin Garcia A, Martin Herrero F, Martin Luengo C. P wave morphology and recurrence after cardioversion of lone atrial fibrillation. Rev Esp Cardiol (Engl Ed). 2012 Mar;65(3):289-90. doi: 10.1016/j.recesp.2011.04.023. Epub 2011 Jul 30. No abstract available. English, Spanish.

    PMID: 21803476BACKGROUND

MeSH Terms

Conditions

Atrial Fibrillation

Interventions

Electric Countershock

Condition Hierarchy (Ancestors)

Arrhythmias, CardiacHeart DiseasesCardiovascular DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeutics

Study Officials

  • Maciej Wójcik, MD, PhD

    Medical University of Lublin, Poland

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Maciej Wójcik, MD, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

February 2, 2018

First Posted

February 12, 2018

Study Start

March 1, 2018

Primary Completion

March 7, 2020

Study Completion

December 7, 2020

Last Updated

January 22, 2020

Record last verified: 2020-01

Locations